{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:55:27Z","timestamp":1789746927397,"version":"4.0.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,6,25]],"date-time":"2015-06-25T00:00:00Z","timestamp":1435190400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s11060-015-1853-7","type":"journal-article","created":{"date-parts":[[2015,6,24]],"date-time":"2015-06-24T04:49:39Z","timestamp":1435121379000},"page":"365-372","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["VB-111: a novel anti-vascular therapeutic for glioblastoma multiforme"],"prefix":"10.1007","volume":"124","author":[{"given":"Aleksandra","family":"Gruslova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Cavazos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica R.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Breitbart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael C.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livnat","family":"Bangio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niva","family":"Yakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Soundararajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Floyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,25]]},"reference":[{"key":"1853_CR1","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1056\/NEJMra0708126","volume":"359","author":"PY Wen","year":"2008","unstructured":"Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359:492\u2013507. doi: 10.1056\/NEJMra0708126","journal-title":"N Engl J Med"},{"key":"1853_CR2","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/nrn2175","volume":"8","author":"RK Jain","year":"2007","unstructured":"Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, Batchelor TT (2007) Angiogenesis in brain tumours. Nat Rev Neurosci 8:610\u2013622. doi: 10.1038\/nrn2175","journal-title":"Nat Rev Neurosci"},{"key":"1853_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejps.2013.10.003","volume":"52","author":"C Carbone","year":"2014","unstructured":"Carbone C, Campisi A, Musumeci T, Raciti G, Bonfanti R, Puglisi G (2014) FA-loaded lipid drug delivery systems: preparation, characterization and biological studies. Eur J Pharm Sci 52:12\u201320. doi: 10.1016\/j.ejps.2013.10.003","journal-title":"Eur J Pharm Sci"},{"key":"1853_CR4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/bs.apha.2014.06.004","volume":"71","author":"TS Salameh","year":"2014","unstructured":"Salameh TS, Banks WA (2014) Delivery of therapeutic peptides and proteins to the CNS. Adv Pharmacol 71:277\u2013299. doi: 10.1016\/bs.apha.2014.06.004","journal-title":"Adv Pharmacol"},{"key":"1853_CR5","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2174\/1389450115666140826122315","volume":"15","author":"W Garrido","year":"2014","unstructured":"Garrido W, Rocha JD, Jaramillo C, Fernandez K, Oyarzun C, San Martin R, Quezada C (2014) Chemoresistance in high-grade gliomas: relevance of adenosine signalling in stem-like cells of glioblastoma multiforme. Curr Drug Targets 15:931\u2013942","journal-title":"Curr Drug Targets"},{"key":"1853_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/1471-2407-14-151","volume":"14","author":"L Tentori","year":"2014","unstructured":"Tentori L, Ricci-Vitiani L, Muzi A, Ciccarone F, Pelacchi F, Calabrese R, Runci D, Pallini R, Caiafa P, Graziani G (2014) Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide. BMC Cancer 14:151. doi: 10.1186\/1471-2407-14-151","journal-title":"BMC Cancer"},{"key":"1853_CR7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2165\/00063030-200822020-00004","volume":"22","author":"JE Frampton","year":"2008","unstructured":"Frampton JE, Keating GM (2008) Bevacizumab: in first-line treatment of advanced and\/or metastatic renal cell carcinoma. BioDrugs 22:113\u2013120","journal-title":"BioDrugs"},{"key":"1853_CR8","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1586\/14737140.2014.956095","volume":"14","author":"A Gubbi","year":"2014","unstructured":"Gubbi A, Kendrick JE, Finkler NJ (2014) The role of bevacizumab in recurrent, platinum-sensitive ovarian cancer. Expert Rev Anticancer Ther 14:1105\u20131113. doi: 10.1586\/14737140.2014.956095","journal-title":"Expert Rev Anticancer Ther"},{"key":"1853_CR9","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1007\/s40265-014-0302-9","volume":"74","author":"GM Keating","year":"2014","unstructured":"Keating GM (2014) Bevacizumab: a review of its use in advanced cancer. Drugs 74:1891\u20131925. doi: 10.1007\/s40265-014-0302-9","journal-title":"Drugs"},{"key":"1853_CR10","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1097\/CAD.0000000000000129","volume":"25","author":"M Maillet","year":"2014","unstructured":"Maillet M, Dreanic J, Dhooge M, Mir O, Brezault C, Goldwasser F, Chaussade S, Coriat R (2014) The predictive and prognostic value of the Glasgow Prognostic Score in metastatic colorectal carcinoma patients receiving bevacizumab. Anti-cancer Drugs 25:1215\u20131219. doi: 10.1097\/CAD.0000000000000129","journal-title":"Anti-cancer Drugs"},{"key":"1853_CR11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s11060-014-1571-6","volume":"120","author":"Y Odia","year":"2014","unstructured":"Odia Y, Shih JH, Kreisl TN, Fine HA (2014) Bevacizumab-related toxicities in the National Cancer Institute malignant glioma trial cohort. J Neuro Oncol 120:431\u2013440. doi: 10.1007\/s11060-014-1571-6","journal-title":"J Neuro Oncol"},{"key":"1853_CR12","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000366","author":"RG Zinner","year":"2014","unstructured":"Zinner RG, Obasaju CK, Spigel DR, Weaver RW, Beck JT, Waterhouse DM, Modiano MR, Hrinczenko B, Nikolinakos PG, Liu J, Koustenis AG, Winfree KB, Melemed SA, Guba SC, Ortuzar WI, Desaiah D, Treat JA, Govindan R, Ross HJ (2014) PRONOUNCE: randomized, open-Label, phase III study of first-line pemetrexed + carboplatin followed by maintenance pemetrexed versus paclitaxel + carboplatin + bevacizumab followed by maintenance bevacizumab in patients ith advanced nonsquamous non-small-cell lung cancer. J Thorac Oncol. doi: 10.1097\/JTO.0000000000000366","journal-title":"J Thorac Oncol"},{"key":"1853_CR13","doi-asserted-by":"publisher","first-page":"483040","DOI":"10.1155\/2012\/483040","volume":"2012","author":"V Cea","year":"2012","unstructured":"Cea V, Sala C, Verpelli C (2012) Antiangiogenic therapy for glioma. J Signal Transduct 2012:483040. doi: 10.1155\/2012\/483040","journal-title":"J Signal Transduct"},{"key":"1853_CR14","first-page":"E5","volume":"20","author":"LC Hou","year":"2006","unstructured":"Hou LC, Veeravagu A, Hsu AR, Tse VC (2006) Recurrent glioblastoma multiforme: a review of natural history and management options. Neurosurg Focus 20:E5","journal-title":"Neurosurg Focus"},{"key":"1853_CR15","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1172\/JCI20007","volume":"113","author":"S Greenberger","year":"2004","unstructured":"Greenberger S, Shaish A, Varda-Bloom N, Levanon K, Breitbart E, Goldberg I, Barshack I, Hodish I, Yaacov N, Bangio L, Goncharov T, Wallach D, Harats D (2004) Transcription-controlled gene therapy against tumor angiogenesis. J Clin Investig 113:1017\u20131024. doi: 10.1172\/JCI20007","journal-title":"J Clin Investig"},{"key":"1853_CR16","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1172\/JCI117784","volume":"95","author":"D Harats","year":"1995","unstructured":"Harats D, Kurihara H, Belloni P, Oakley H, Ziober A, Ackley D, Cain G, Kurihara Y, Lawn R, Sigal E (1995) Targeting gene expression to the vascular wall in transgenic mice using the murine preproendothelin-1 promoter. J Clin Investig 95:1335\u20131344. doi: 10.1172\/JCI117784","journal-title":"J Clin Investig"},{"key":"1853_CR17","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/sj.gt.3301472","volume":"8","author":"N Varda-Bloom","year":"2001","unstructured":"Varda-Bloom N, Shaish A, Gonen A, Levanon K, Greenbereger S, Ferber S, Levkovitz H, Castel D, Goldberg I, Afek A, Kopolovitc Y, Harats D (2001) Tissue-specific gene therapy directed to tumor angiogenesis. Gene Ther 8:819\u2013827. doi: 10.1038\/sj.gt.3301472","journal-title":"Gene Ther"},{"key":"1853_CR18","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.1158\/1078-0432.CCR-12-2079","volume":"19","author":"AJ Brenner","year":"2013","unstructured":"Brenner AJ, Cohen YC, Breitbart E, Bangio L, Sarantopoulos J, Giles FJ, Borden EC, Harats D, Triozzi PL (2013) Phase I dose-escalation study of VB-111, an antiangiogenic virotherapy, in patients with advanced solid tumors. Clin Cancer Res 19:3996\u20134007. doi: 10.1158\/1078-0432.CCR-12-2079","journal-title":"Clin Cancer Res"},{"key":"1853_CR19","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1093\/neuonc\/nos060","volume":"14","author":"WT Phillips","year":"2012","unstructured":"Phillips WT, Goins B, Bao A, Vargas D, Guttierez JE, Trevino A, Miller JR, Henry J, Zuniga R, Vecil G, Brenner AJ (2012) Rhenium-186 liposomes as convection-enhanced nanoparticle brachytherapy for treatment of glioblastoma. Neuro Oncol 14:416\u2013425. doi: 10.1093\/neuonc\/nos060","journal-title":"Neuro Oncol"},{"key":"1853_CR20","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1215\/15228517-2007-024","volume":"9","author":"S Bouard de","year":"2007","unstructured":"de Bouard S, Herlin P, Christensen JG, Lemoisson E, Gauduchon P, Raymond E, Guillamo JS (2007) Antiangiogenic and anti-invasive effects of sunitinib on experimental human glioblastoma. Neuro Oncol 9:412\u2013423. doi: 10.1215\/15228517-2007-024","journal-title":"Neuro Oncol"},{"key":"1853_CR21","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1101\/gad.1596707","volume":"21","author":"FB Furnari","year":"2007","unstructured":"Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, Chin L, DePinho RA, Cavenee WK (2007) Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21:2683\u20132710. doi: 10.1101\/gad.1596707","journal-title":"Genes Dev"},{"key":"1853_CR22","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00109-013-1019-z","volume":"91","author":"Y Soda","year":"2013","unstructured":"Soda Y, Myskiw C, Rommel A, Verma IM (2013) Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme. J Mol Med 91:439\u2013448. doi: 10.1007\/s00109-013-1019-z","journal-title":"J Mol Med"},{"key":"1853_CR23","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.neo.2014.06.003","volume":"16","author":"GJ Baker","year":"2014","unstructured":"Baker GJ, Yadav VN, Motsch S, Koschmann C, Calinescu AA, Mineharu Y, Camelo-Piragua SI, Orringer D, Bannykh S, Nichols WS, deCarvalho AC, Mikkelsen T, Castro MG, Lowenstein PR (2014) Mechanisms of glioma formation: iterative perivascular glioma growth and invasion leads to tumor progression, VEGF-independent vascularization, and resistance to antiangiogenic therapy. Neoplasia 16:543\u2013561. doi: 10.1016\/j.neo.2014.06.003","journal-title":"Neoplasia"},{"key":"1853_CR24","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1158\/0008-5472.CAN-14-0685","volume":"74","author":"MS Nandhu","year":"2014","unstructured":"Nandhu MS, Hu B, Cole SE, Erdreich-Epstein A, Rodriguez-Gil DJ, Viapiano MS (2014) Novel paracrine modulation of Notch-DLL4 signaling by fibulin-3 promotes angiogenesis in high-grade gliomas. Cancer Res 74:5435\u20135448. doi: 10.1158\/0008-5472.CAN-14-0685","journal-title":"Cancer Res"},{"key":"1853_CR25","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/sj.cgt.7700750","volume":"12","author":"C Conrad","year":"2005","unstructured":"Conrad C, Miller CR, Ji Y, Gomez-Manzano C, Bharara S, McMurray JS, Lang FF, Wong F, Sawaya R, Yung WK, Fueyo J (2005) Delta24-hyCD adenovirus suppresses glioma growth in vivo by combining oncolysis and chemosensitization. Cancer Gene Ther 12:284\u2013294. doi: 10.1038\/sj.cgt.7700750","journal-title":"Cancer Gene Ther"},{"key":"1853_CR26","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1593\/neo.04391","volume":"7","author":"H Jiang","year":"2005","unstructured":"Jiang H, Gomez-Manzano C, Alemany R, Medrano D, Alonso M, Bekele BN, Lin E, Conrad CC, Yung WK, Fueyo J (2005) Comparative effect of oncolytic adenoviruses with E1A\u201355 kDa or E1B\u201355 kDa deletions in malignant gliomas. Neoplasia 7:48\u201356. doi: 10.1593\/neo.04391","journal-title":"Neoplasia"},{"key":"1853_CR27","unstructured":"Samoto K, Ehtesham M, Perng GC, Hashizume K, Wechsler SL, Nesburn AB, Black KL, Yu JS (2002) A herpes simplex virus type 1 mutant with gamma 34.5 and LAT deletions effectively oncolyses human U87 glioblastomas in nude mice. Neurosurgery 50:599\u2013605; discussion 605\u2013596"},{"key":"1853_CR28","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1215\/15228517-2008-061","volume":"10","author":"C Gomez-Manzano","year":"2008","unstructured":"Gomez-Manzano C, Holash J, Fueyo J, Xu J, Conrad CA, Aldape KD, de Groot JF, Bekele BN, Yung WK (2008) VEGF Trap induces antiglioma effect at different stages of disease. Neuro Oncol 10:940\u2013945. doi: 10.1215\/15228517-2008-061","journal-title":"Neuro Oncol"},{"key":"1853_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/neuonc\/noq150","volume":"13","author":"LL Muldoon","year":"2011","unstructured":"Muldoon LL, Gahramanov S, Li X, Marshall DJ, Kraemer DF, Neuwelt EA (2011) Dynamic magnetic resonance imaging assessment of vascular targeting agent effects in rat intracerebral tumor models. Neuro Oncol 13:51\u201360. doi: 10.1093\/neuonc\/noq150","journal-title":"Neuro Oncol"},{"key":"1853_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2214\/AJR.06.0280","volume":"188","author":"JM Provenzale","year":"2007","unstructured":"Provenzale JM (2007) Imaging of angiogenesis: clinical techniques and novel imaging methods. AJR 188:11\u201323. doi: 10.2214\/AJR.06.0280","journal-title":"AJR"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-015-1853-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-015-1853-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-015-1853-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-015-1853-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T02:01:03Z","timestamp":1599184863000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-015-1853-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,25]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["1853"],"URL":"https:\/\/doi.org\/10.1007\/s11060-015-1853-7","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,25]]}}}